STERILIZATION
Product
is
supplied
sterile
(according
to
the
definition
reported
on
the
standard
UNI
EN
556).
In
particular
metal
components
are
sterilized
through
rays
(Beta
or
Gamma)
according
to
the
normative
UNI
EN
ISO
11137-‐1;-‐2;-‐3
while
the
elements
manufactured
in
polyethylene
are
sterilized
with
ethylene
oxide
(ETO)
according
the
normative
UNI
EN
ISO
11135-‐1.
Both
sterilizations
are
guaranteed
for
10
years.
The
sterilization
method
is
indicated
on
the
label
in
which
is
also
reported
the
expiry
date
that
indicates
the
maximum
time
to
use
the
product.
The
packaging
(double
pack)
allows
products
to
be
handled
by
non-‐
sterile
personnel
during
conservation.
The
extraction
of
the
product
must
be
carried
out
by
sterile
operating
personnel.
If
at
any
time
during
unpacking
an
anomalous
situation
arises,
it
is
advisable
not
to
use
the
piece
because
there
is
a
risk
that
it
may
have
lost
the
sterility
and
its
return
to
Gruppo
Bioimpianti
which
w ill
c arry
o ut,
i f
i t
i s
p ossible,
a
r econditioning.
IDENTIFICATION
A ND
T RACEABILITY
All
products
manufactured
by
Gruppo
Bioimpianti
s.r.l.
are
identified
by
the
label
on
the
packaging
which
states
the
contents,
size
or
another
parameter
which
indicates
the
dimensions,
the
product's
code,
the
production
batch,
the
sterility
symbol
with
the
expiration
date
and
the
sterilization
method.
To
guarantee
external
t raceability
e ven
a fter
i mplantation
t hey
a re
p rovided
a
s eries
o f
l abels
i nside
t he
p ackaging,
w hich
shall
b e
u sed
o n
t he
s urgery
r egister
a nd
o n
t he
p atients'
m edical
r ecords.
PRESERVATION
Our
devices
should
be
kept
in
hygienically
controlled
surroundings.
The
packaging
system,
however,
guarantees
the
necessary
protection
against
scratches,
damages
or
loss
of
sterility
of
the
product
during
routine
handling.
The
handling
and
the
preserving
of
the
product
have
to
be
in
order
to
not
damage
the
packaging:
If
damage
should
occur,
the
product
should
be
returned,
after
due
consideration,
to
Gruppo
Bioimpianti
S.r.l.
for
any
necessary
re-‐processing
or
elimination.
Do
not
use
the
product
if
the
packaging
is
opened
o r
d amaged
o r
i n
c ase
t he
e xpiry
d ate
i s
p assed.
INDICATIONS
K-‐MOD:
The
modular
knee
arthroprosthesis
K-‐MOD
is
intended
for
primary
total
knee
replacement.
The
main
indications
t o
t he
r eplacement
o f
t he
k nee
j oint
a re
t he
f ollowing:
1. Joint
d iseases
( as
f or
e xample
o steoarthritis,
r heumatoid
a rthritis,
p ost-‐traumatic
a rthritis..);
2. Functional
d eformities:
v arus/valgus
k nee
o r
p ost-‐traumatic
d eformity;
3. Correction
o r
r evision
o f
f ailed
o steotomy,
a rthrodesis.
The
femoral
components
and
the
tibial
trays
which
don't
present
a
porous
coating,
together
with
the
patellar
c omponent,
a re
E XCLUSIVELY
i ndicated
f or
a
c emented
a pplication.
T he
m etal
c omponents
r ealized
with
t he
p orous
c oating
a re
i ndicated
f or
a
c ementless
a pplication.
The
a nallergic
v ersion
c haracterized
s olely
b y
a
T iNbN
c oating
s hall
b e
i mplanted
t hrough
c ementation.
T he
anallergic
uncemented
version,
instead,
characterized
both
by
a
TiNbN
and
a
porous
coating,
is
indicated
for
c ementless
a pplication.
The
fixed-‐bearing
Ultra
Congruent
design,
the
PS
design
(both
in
the
mobile
and
fixed
bearing
version)
and
the
mobile
bearing
APS
design
are
indicated
in
case
of
Posterior
Cruciate
Ligament
(PCL)
sacrificing,
when
it's
not
necessary
its
substitution,
while
the
CR
model
provides
its
preservation.
The
Dynamic
Congruence
fixed
b earing
a nd
t he
U ltra
C ongruent
m obile
b earing
a re
i nstead
i ndicated
b oth
i n
c ase
o f
P CL
p reservation
(it
has
in
fact
a
slot
for
the
insertion
of
the
PCL)
and
in
case
that
it
is
necessary
to
remove
it.
This
is
due
to
the
p articular
g eometry
o f
t he
i nsert
w hich
g uarantees
i ts
h igh
s tability.